Atnaujinkite slapukų nuostatas

El. knyga: Sphingolipid Metabolism and Metabolic Disease

Edited by
Kitos knygos pagal šią temą:
Sphingolipid Metabolism and Metabolic DiseaseDidesnis paveikslėlis
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

This book provides an up-to-date review of the fundamentals of sphingolipid metabolism and its role in metabolic diseases. Focusing on the sphingolipid de novo synthesis pathway, the effect of sphingomyelin, ceramide, and sphingosine-1-phosphate, and linkage between sphingolipids and other lipids, such as cholesterol, it covers serine palmitoyltransferase, ceramide synthases, ceramidases, sphingosine kinases, and sphingomyelin synthases, and more. While highlighting how rare diseases related to abnormal glycosphingolipid metabolism, this publication introduces sphingolipid metabolism-related diseases, such as lung diseases and cancers, as well as sphingolipid circadian regulation. The book demonstrates advances and limitations of research on sphingolipid metabolism and its roles in metabolic diseases and other diseases. It offers graduate students and researchers a coherent overview of sphingolipids, as well as the limitations of current research in the field, and promotes further studies on metabolic diseases, as well as pharmaceutical research on drug discovery based on sphingolipid de novo synthase.
Chapter 1: Sphingolipids and Cholesterol.
Chapter 2: Sphingolipids in
adipose: kin or foe?.
Chapter 3: De novo sphingolipid biosynthesis in
atherosclerosis.
Chapter 4: Serine Palmitoyltransferase Subunit 3 and
Metabolic Diseases.
Chapter 5: Molecular mechanisms of sphingolipid
transport on plasma lipoproteins.
Chapter 6: Sphingosine 1-phosphate
metabolism and signaling.
Chapter 7: Sphingomyelin synthase family and
phospholipase Cs.
Chapter 8: Sphingolipid metabolism and signaling in
endothelial cell functions.
Chapter 9: Cholesterol metabolism in chronic
kidney disease: physiology, pathologic mechanisms, and treatment.- Chapter
10: Sphingolipids and asthma.- Chaper 11: Manifold Roles of Ceramide
Metabolism in Nonalcoholic Fatty Liver Disease and Liver Cancer.
Chapter 12:
Drug development in the field of sphinogolipid metabolism.
Chapter 13: Rare
diseases in glycosphingolipid metabolism.
Dr. Xian-Cheng Jiang (PhD) is a Distinguished Professor at the State University of New York (SUNY). He is working at the Department of Cell Biology, SUNY Downstate Health Sciences University. His research focuses on lipid metabolism and metabolic diseases, such as atherosclerosis, metabolic syndrome, obesity and liver steatosis, particularly how sphingolipid metabolism influences plasma lipoprotein metabolism, cell membrane lipid composition and function, and the development of metabolic diseases.
Daugiau apie elektronines knygas Daugiau apie elektronines knygas
Pastovi nuoroda: https://www.kriso.lt/db/97898119039466e.html
Raktažodžiai: